From: Electrochemotherapy: from the drawing board into medical practice
Drug tested | In vitro potentiation | In vivo potentiation |
---|---|---|
Bleomycin | Yes | |
Cisplatin | ||
Calcium | Yes [31] | |
Netropsin | Yes; 200-fold [1] | – |
Carboplatin | – | |
2-N-methyl-9-hydroxy-ellipticinium (NMHE) | Yes; 4-fold [1] | – |
Vincristine | Yes; 1.3–3.4-fold [18] | – |
ActiNomycin D | Yes; 2–3-fold [1] | – |
Cytarabine | Yes; 2-fold [18] | – |
Oxaliplatin | Yes [29] | – |
Platinum (II) complex 3P-SK | Yes [29] | Yes [29] |
Platinum (II) complex PtAMP | Yes [29] | – |
Mitomycin C | – | |
Vinblastine | Yes but low; 1.1–1.3-fold [18] | – |
5-fluorouracil | – | |
Paclitaxel | – | |
Doxorubicin | – | |
Nimustine hydrochloride (ACNU) | No [27] | – |
Methotrexate | No [1] | – |
9-OH-ellipticine | No [1] | – |
Didemnin B | No [1] | – |
Melphalan | No [1] | – |
Mithramycin | No [1] | – |
Taxotere | No [1] | – |
DauNorubicin | No [17] | – |
Adriamycin | No [32] | No [28] |
Etoposide | – | |
Ancitabine | ND [18] | – |
Gemcitabine | ND [18] | – |